A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan

Fimasartan 30 mg

DRUG

Valsartan

Valsartan 80 mg

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Inje University

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT01878201 - A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension | Biotech Hunter | Biotech Hunter